Free Trial

ACADIA Pharmaceuticals (ACAD) Insider Trading & Ownership

$15.10
+0.38 (+2.58%)
(As of 10/4/2024 08:49 PM ET)

ACADIA Pharmaceuticals (NASDAQ:ACAD) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
28.30%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$2.90 M
Get ACAD Insider Trade Alerts

Want to know when executives and insiders are buying or selling ACADIA Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ACAD Insider Buying and Selling by Quarter

ACADIA Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/19/2024Brendan TeehanCOOSell9,534$15.28$145,679.52  
8/19/2024Mark C SchneyerCFOSell9,733$15.28$148,720.24  
8/19/2024Stephen DavisCEOSell31,747$15.28$485,094.16  
6/10/2024Mark C SchneyerCFOSell975$14.79$14,420.25  
5/2/2024Brendan TeehanCOOSell3,477$16.94$58,900.38  
5/2/2024James KiharaInsiderSell1,326$16.94$22,462.44  
10X More Profitable Than Physical Gold? (Ad)

The smart money is piling into gold and gold stocks. There's a backdoor gold play that could deliver 10 TIMES bigger gains than physical gold. That's why I've put together a special presentation on this opportunity...

5/2/2024Mark C SchneyerCFOSell3,503$16.94$59,340.82  
5/2/2024Stephen DavisCEOSell11,427$16.94$193,573.38  
4/8/2024Brendan TeehanCOOSell2,568$17.87$45,890.16  
4/8/2024James KiharaInsiderSell1,790$17.87$31,987.30  
4/8/2024Mark C SchneyerCFOSell2,716$17.87$48,534.92  
4/8/2024Stephen DavisCEOSell26,574$17.87$474,877.38  
3/27/2024Brendan TeehanCOOSell5,140$17.90$92,006.00  
3/27/2024Mark C SchneyerCFOSell5,434$17.90$97,268.60  
3/27/2024Stephen DavisCEOSell17,714$17.90$317,080.60  
2/26/2024Brendan TeehanCOOSell624$24.67$15,394.08  
2/26/2024James KiharaInsiderSell474$24.67$11,693.58  
2/26/2024Mark C SchneyerCFOSell772$24.67$19,045.24  
2/26/2024Stephen DavisCEOSell5,577$24.67$137,584.59  
1/8/2024Austin D KimEVPSell590$29.96$17,676.40  
1/8/2024Brendan TeehanCOOSell731$29.96$21,900.76  
1/8/2024Stephen DavisCEOSell3,732$29.96$111,810.72  
12/15/2023James KiharaInsiderSell2,000$28.30$56,600.00  
11/20/2023Brendan TeehanCOOSell4,960$22.64$112,294.40  
11/20/2023James KiharaInsiderSell1,985$22.64$44,940.40  
11/20/2023Mark C SchneyerCFOSell5,108$22.64$115,645.12  
(Data available from 1/1/2013 forward)

ACAD Insider Trading Activity - Frequently Asked Questions

The list of insiders at ACADIA Pharmaceuticals includes Austin D Kim, Brendan Teehan, Bros. Advisors Lp Baker, James Kihara, Laura Brege, Mark C Schneyer, Srdjan R Stankovic, and Stephen Davis. Learn more on insiders at ACAD.

28.30% of ACADIA Pharmaceuticals stock is owned by insiders. Learn more on ACAD's insider holdings.

The following insider purchased ACAD shares in the last 24 months: Bros. Advisors Lp Baker ($5,312,036.73).

Insiders have purchased a total of 209,053 ACAD shares in the last 24 months for a total of $5,312,036.73 bought.

The following insiders have sold ACAD shares in the last 24 months: Austin D Kim ($448,172.57), Brendan Teehan ($887,793.34), James Kihara ($430,341.60), Laura Brege ($340,040.00), Mark C Schneyer ($1,207,450.29), Srdjan R Stankovic ($48,798.35), and Stephen Davis ($6,773,503.05).

Insiders have sold a total of 453,985 ACADIA Pharmaceuticals shares in the last 24 months for a total of $10,136,099.20 sold.

ACADIA Pharmaceuticals Key Executives



This page (NASDAQ:ACAD) was last updated on 10/7/2024 by MarketBeat.com Staff
From Our Partners